Full-Time

Manager – Flow Cytometry Account

Posted on 11/4/2025

Deadline 11/3/27
Sysmex

Sysmex

1,001-5,000 employees

Manufactures automated hematology analyzers and diagnostics

Compensation Overview

$100k - $120k/yr

+ Bonus + 401(k) Match

Washington, USA + 2 more

More locations: Oregon, USA | California, USA

In Person

Up to 70% travel required.

Category
Sales & Account Management (1)
Requirements
  • Bachelor’s degree or 5-7 years of experience in flow cytometry, immunology, cell biology or related pathology discipline.
  • General computer knowledge in a Windows environment is required.
  • Excellent command of English, both verbal and written.
  • Demonstrated ability to explain in simple and understandable terms complex technical information associated with Sysmex instruments and reagents.
  • Team orientation; demonstrated facilitation skills.
  • Maintaining stable performance under project timelines.
  • Take initiative to make changes to improve how work is done, focus on process improvement; promote customer satisfaction; support sales objectives and organizational directives; provide data to the organization on customer use/preferences leading to customer driven design/customer usability.
  • The ability to administer a designated sales territory with support to achieve annual sales objectives as directed by leadership.
  • Formulate and implement a detailed Territory Plan, along with appropriate sales strategies outlining the use of all available resources.
  • Execute all stages of the sales process including prospecting, qualifying, development, demonstration, proposal presentation, negotiation and closing.
  • Prepares all necessary documentation to process the purchase orders and contracts received from the customer’s laboratory, purchasing or materials management.
  • Present and promote all Sysmex product lines to position our product’s technological superiority, feature and benefits over our competitors.
  • Administers the proper and responsible use of the company assets and operate within the company guidelines.
  • Maintain proper records of customer interactions (sales and support) using the appropriate Company tools (CRM).
  • Additional duties and responsibilities according to business needs.
Responsibilities
  • Lead in the pre-sales and sales activities to properly promote the Company’s Flow Cytometry portfolio of products to ensure financial targets are achieved.
  • Participate, and be able to present in trainings and trade shows, seminars and workshops as needed.
  • Administers a designated sales territory with the support of corporate and field members to achieve the annual sales objectives established by the National Sales Director.
  • Formulate and implement a detailed Territory Plan, along with appropriate sales strategies outlining the use of all available resources.
  • Execute all stages of the sales process including prospecting, qualifying, development, demonstration, proposal presentation, negotiation and closing.
  • Prepares all necessary documentation to process the purchase orders and contracts received from the customer’s laboratory, purchasing or materials management.
  • Present and promote all Sysmex product lines to position our product’s technological superiority, feature and benefits over our competitors.
  • Administers the proper and responsible use of the company assets and operate within the company guidelines.
  • Maintain proper records of customer interactions (sales and support) using the appropriate Company tools (CRM).
  • Additional duties and responsibilities according to business needs.

Sysmex designs and sells instruments and reagents for in-vitro diagnostics, with a focus on automated hematology analyzers that count and evaluate blood cells, enabling clinical decision-making. Over time, it expanded into genetics through the acquisition of Oxford Gene Technology and into rapid antimicrobial testing with Astrego, broadening its diagnostic portfolio. The company differentiates itself by growing through acquisitions to build a diverse, global product line and by maintaining a strong brand presence in workflows for hematology, genetics, and infectious disease testing across more than 190 countries. Its goal is to provide essential, reliable diagnostic tools that support healthcare worldwide, helping clinicians diagnose and treat diseases faster and more accurately.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Kobe, Japan

Founded

1968

Simplify Jobs

Simplify's Take

What believers are saying

  • XR-Series and CN-9000 upgrades target high-throughput labs needing faster workflows.[6]
  • Brazil expansion should strengthen regional supply, distribution, and service for Latin America.[1]
  • Existing XN-Series familiarity reduces switching friction and supports installed-base retention.[6]

What critics are saying

  • Abbott, Beckman Coulter, and Siemens pressure Sysmex in core hematology and automation.[5][6]
  • Revenue depends on refresh cycles and consumables, exposing growth to delayed lab replacements.[1][3]
  • Brazil expansion execution risks could disrupt reagent availability and service ramp-up.[1]

What makes Sysmex unique

  • Founded in Kobe in 1968, Sysmex built hematology leadership from TOA Medical Electronics.[1][6]
  • Its business spans diagnostic instruments, reagents, and software across more than 190 countries.[1][3]
  • Sysmex couples analyzers with recurring consumables and service across hematology and hemostasis.[1][6]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Sysmex who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Parental Leave

Bereavement Leave

401(k) Retirement Plan

401(k) Company Match

Annual Incentive Bonus

Growth & Insights and Company News

Headcount

6 month growth

28%

1 year growth

28%

2 year growth

29%
Sysmex Corporation
Mar 5th, 2026
Sysmex Acquires Additional Shares in RIKEN GENESIS and Converts Company to a Subsidiary

This section provides Sysmex’s most recent news releases related to IR information, products and support, research and development, corporate information and other notifications.

Sysmex Corporation
Jan 22nd, 2026
Launch of "CN(TM)-9000 Automated Hemostasis Solution" for Large-Scale Laboratories in North America - Supporting the Optimization of Laboratory Workflow - (Sysmex America)

Launch of "CN(TM)-9000 Automated Hemostasis Solution" for large-scale laboratories in North America - supporting the optimization of laboratory workflow - (Sysmex America). Sysmex America, Inc., a Sysmex Group company, has launched the "CN(TM)-9000 Automated Hemostasis Solution" as a new addition to the CN-Series for hemostasis testing in the North American market. This product supports further automation and increased efficiency in testing operations at large hospitals and testing centers with high test volumes. In addition to standalone operation, the CN(TM)-9000 is compatible with Total Laboratory Automation (TLA) lines, enabling flexible system configurations tailored to the size and operational needs of each laboratory. For further details, please refer to Sysmex America's press release. Going forward, Sysmex will continue to work to further enhance the value of hemostasis through product development and services that address the increasingly varied and sophisticated needs of medical settings, thereby contributing to improved patient outcomes. * The purpose of this news is to communicate its business activities to its stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.

LabX Media Group
Jan 21st, 2026
Sysmex America Launches CN-9000 to Streamline Hemostasis Workflow in Busy Clinical Labs

Sysmex America launches CN-9000 to streamline hemostasis workflow in busy clinical labs. Designed for high-throughput labs, the CN-9000 boosts efficiency, reduces manual handling, and integrates seamlessly with lab automation systems. Listen with Speechify Sysmex America, Inc., a leader in diagnostic solutions, has announced the launch of the CN-9000 Automated Hemostasis Solution, the latest innovation in its CN-Series. This new system is engineered to help clinical laboratories of all sizes - especially high-volume ones - optimize workflow and keep up with increasing testing demands. With the ability to process up to 1,000 samples per hour, the CN-9000 supports continuous sample loading, automated rerun/reflex testing, and seamless connectivity to compatible total laboratory automation (TLA) lines. Features like closed-tube sampling and Preanalytical Sample Integrity (PSI(TM) checks enhance safety while reducing errors and manual labor. Key features of the CN-9000. * High-throughput processing: up to 1,000 samples/hour * Automated rerun/reflex testing * Closed-tube sampling and PSI(TM) checks * Modular setup with support for CN-3000/CN-6000 analyzers * Optional integration with Sysmex TS-10(TM) Tube Sorter and Archiver * Flexible layout with turn modules for space-saving configurations "Sysmex America's hemostasis solutions help labs keep up with growing testing demands," said Dan Zortman, CEO of Sysmex America. "With the CN-Series, CN-9000, we're giving labs a reliable, high-throughput, walkaway solution that makes daily operations easier and more efficient." Supporting smarter, scalable lab operations. The CN-9000's modular design allows for integration of up to three analyzers and multiple accessories, making it highly adaptable for both current and future lab needs. With intelligent tube routing and minimized manual intervention, the CN-9000 supports lab managers in achieving consistent, scalable, and efficient testing operations. For more information about the CN-9000 and Sysmex America's full hemostasis product line, visit www.sysmex.com. * craig bradley craig bradley bsc (hons), msc, has a strong academic background in human biology, cardiovascular sciences, and biomedical engineering. Since 2025, he has been working with labx media group as a SEO editor. Craig can be reached at [email protected]. View full profile.

Sysmex Corporation
Jan 19th, 2026
Sysmex Makes Megakaryon Corporation into a Subsidiary, Aiming at Accelerating Efforts in the Field of Regenerative and Cellular Medicine

Sysmex Corporation’s corporate philosophy defines its mission as “Shaping the advancement of healthcare.” On that basis, we provide diagnostic instruments, reagents and software throughout the world.

Sysmex Corporation
Aug 27th, 2025
Sysmex America Recognized with Brandon Hall Group Bronze Award for Leadership Development

Chicago - August 27, 2025 - Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has been recognized with a Brandon Hall Group(TM) Bronze award for excellence in the Best Development Program for Frontline Leaders category for the Considering the Shift Program offered through Sysmex University.

INACTIVE